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The rat adrenal medulla consists mainly o f low proliferat­
ing, highly differentiated parenchymal cells. By immuno- 
cytochemical techniques, two types of patenchymal cells can 
be identified, norepinephrine (NE) - and epinephrine (E) - 
storing cells. Bromodeoxyuridine (BrdU), a thymidine ana­
logue often used to identify proliferating cells, can also be 
detected by immunocytochemical techniques. We developed 
double- and triple-labeling procedure(s) for simultaneous 
visualization of NE, E, dopamine [3-hydroxylase (DBH), 
phenylethanolamine-N methyl transferase (PNMT), and 
BrdU in rat adrenal medulla. BrdU was administered to 7- 
week-old Wistar rats by mini-osmotic pumps. Tissues were 
fixed by perfusion with 4% paraformaldehyde and embed- 
ded in paraffin. By immunocytochemistry, fust NE, E, DBH, 
and/or PNMT was detected by an indirect immunoalkaline 
phosphatase technique with Fast Red or Fast Blue as sub­
Introduction
Cell kinetic studies based on mitotic counts have suggested that 
the parenchymal cells of the adrenal medulla of adult rats are not 
able to divide (Mitchell, 1948; Jackson, 1919), i.e., are terminally 
differentiated. Malvaldi et al. (1968), however, showed that in the 
chromaffin cells of the adrenal medulla mitotic figures occur if mi­
totic arrest is induced with colchicine. Messier and Leblond (I960) 
also found low proliferative activity in adrenal medullary cells using 
[^H]-thymidine incorporation during the S-phase of the cell cycle.
Bromodeoxyuridine (BrdU), a thymidine analogue incorporated 
during DNA replication, can easily be detected by immunocyto- 
chemical techniques (Gratzner, 1982). This principle has been 
adopted to identify cells that are exposed to BrdU during the S-phase 
or are derived from previously BrdU-labeled cells. Since its introduc­
tion, this method has been used for cell kinetic studies in several
1 Preliminary results were reported at the 9th International Congress 
of Histochemistry and Cytochemistry, August 30-September 4, 1992, Maas­
tricht, The Netherlands.
2 Correspondence to: Dr. AA.J. Verhofstad, Dept, of Pathology, U. of 
Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
strate. Next, incorporation of BrdU was detected with an in­
direct immunoperoxidase procedure using diaminobenzidine 
(DAB). Both NE- and E-storing cells, as well as endothelial 
cells, can incorporate BrdU, i.e., are able to divide. Occa­
sionally, we also found BrdU-stained mitotic figures in E, 
PNMT and DBH immunoreactive cells. No BrdU incorpo­
ration was found in the post-ganglionic neurons of the adre­
nal medulla. The procedures described enable a detailed cell 
kinetic study of the NE- and E-storing cells in the adrenal 
medulla, particularly in the rat, which can lead to a better 
understanding of cell renewal in the adrenal medullary tis­
sue under normal and pathological conditions. (JHistochem  
Cytochem 43.39-46, 1995)
KEY WORDS: Adrenal medulla; 5-bromo-2-deoxyuridine; Norepi­
nephrine; Epinephrine; Simultaneous immunostaining; Cell prolifer­
ation; Rat.
types of tissue (e.g., Patel et al., 1993; De Bruine et al,, 1992; Hyatt 
and Beebe, 1992; Soriano and Del Rio, 1991; Frederiks et al., 1990; 
Magaud et aL, 1989; De Fazio et al., 1987; Schutte et al., 1987a; 
Dolbeare et al., 1983). Especially in slowly proliferating tissues such 
as the adrenal medulla, this technique has opened new possibili­
ties to detect cell proliferation. Thus, for example, by continuous 
BrdU administration to adult rats for 73 days using mini-osmotic 
pumps in the adrenal medulla, about 40-50% of parenchymal cells 
appeared to be labeled (Verhofstad, 1993). These labeled cell nuclci 
were randomly localized throughout the adrenal medulla just like 
the mitotic figures described by Malvaldi.
The parenchyma of the adrenal medulla of most mammals con­
sists of two different cell types synthesizing and storing either 
norepinephrine (NE) or epinephrine (E) (Coupland, 1971,1989). 
Among other techniques, these cells can be identified by immu- 
nocytochemistry using antibodies to NE and E (Verhofstad et al., 
1980,1983) or the bio synthesizing enzymes dopamine P-hydroxylase 
(DBH) and phenylethanolamine-N methyl transferase (PNMT) 
(Hokfelt et al., 1973; Goldstein et al., 1971) (see also Table 3). With 
both sets of antibodies, i.e., antibodies to NE and E or DBH and 
PNMT, identical results can be obtained. However, antibodies to
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DBH and PNMT do not always crossreact with the enzymes of other 
species to the same extent, or may even not crossreact at all. There- 
fore, antibodies to NE and E, molecules that are not immunogenic 
by themselves, provide a more universal procedure to identify NE- 
and E-storing cells (for detailed discussion see Verhofstad et al.,
1983,1985,1989). Limited efforts to combine BrdU cytochemistry 
and methods to identify NE- and E-storing cells have been reported. 
Only Tischler described the combined staining of BrdU and PNMT 
(Tischler et aJM 1989) or tyrosine hydroxylase (Tischler et al., 1992) 
in rat adrenal medullary cells.
In the present study we describe immunocytochemical stain­
ing procedures that allow simultaneous visualization of BrdU and 
one or two catecholamines or catecholamine-synthesizing enzymes. 
These double- and triple-staining procedures enable the demon­
stration of BrdU incorporation into the NE- and E-storing cells, 
offering new possibilities to study renewal of these cells in the adrenal 
medulla under normal and pathological conditions.
Materials and Methods
Animals. Male Wistar rats (Charles River Wiga; Sulzfeld, Germany) 
weighing approximately 200 g and aged 7 weeks were used. During the 
BrdU labeling experiments they were housed in Macrolon Type 3 cages with 
water and standard laboratory food (RMH Hope Farms; Woerden, The 
Netherlands) ad libitum, maintained on a 12-hr lightrdark cycle in air- 
conditioned rooms (20-23°C), and treated according to the institution’s 
guidelines for care and use of laboratory animals.
BrdU Administration. BrdU (Serva; Heidelberg, Germany) dissolved 
in PBS (0.01 M, pH 7.4, with or without 0.37% N H 3 to improve the solu­
bility) at a concentration of 30 mg/ml was sterilized by a pyrogen-free 
microfilter (Millipore, 0.2 }4.m). The BrdU solution was given continuously 
to ob tain a reasonable number of labeled cell nuclei in the adrenal medulla 
using Alzet mini-osmotic pumps (Alza; Palo Alto, CA) Type 2001 with 
a capacity of 200 |il and a mean pumping rate of 1 jal/hr. The filled pumps 
were weighed to check the amount of solution loaded. Before implanta­
tion the pumps were kept in a sterile isotonic saline solution at 37°C for 
at least 4 hr to obtain a steady-state pumping rate. Under semi-sterile cir­
cumstances and light ether anesthesia, the pumps were implanted IP in 
four rats and removed after 1 week. In two of these rats pumps were replaced 
to complete the 2-week administration of BrdU. At the end of each label­
ing experiment the peritoneal cavity of the animals was checked for the 
presence of inflammation and formation of adhesions.
Tissue Preparation. Rats without BrdU incorporation and rats at the 
end of a 1- or 2-week BrdU labeling period were anesthetized by IP injec­
tion o f sodium pentobarbital (Narcovet; Arnhem, The Netherlands) (60 
mg/kg bw) and fixed by perfusion through the left ventricle of the heart 
with ice-cold 4% paraformaldehyde (Merck 4005; Darmstadt, Germany) 
in 0.1 M phosphate buffer, pH 7.3 (Pease, 1962). After 15 min the adrenal 
glands and several other tissues were dissected and post-fixed in the same 
fixative for 2 hr at 4°C. The adrenals were then cut in two equal parts with 
stainless steel razor blades. Tissues were rinsed in PBS, dehydrated in a graded 
series of ethanol, rinsed in xylene two times for 30 min each and impreg­
nated twice for 30 min with paraffin (Paraplast Plus) (Oxford Labware; St 
Louis, MO) under vacuum. Paraffin sections were cut at 4 Jim thick, mounted 
on glass slides with Tissue Adhesive (Laboratory-Service Benelux; Apel- 
doorn, The Netherlands), and kept overnight at 3 7°C to improve adhesion 
of the sections to the slides.
Antisera. A mouse monoclonal antibody (MAb) was used to stain BrdU 
This MAb (clone II B 5) was prepared by Schutte et al. (1987a). To stain 
NE and E cells, polyclonal antisera to NE, E, DBH, and PNMT were used.
The preparation and characterization of these sera have been reported else­
where (Verhofstad et a l, 1980,1983; Goldstein et al., 1971). All other anti­
bodies were obtained from Dakopatts (Copenhagen, Denmark). Antisera 
were diluted in a 0.15 M PBS solution containing 2% bovine albumin (Sigma; 
St Louis, MO) and 0.1% Triton X-100 (Sigma) as indicated in Table 1 .
Staining Experiments. Tissue sections were cleared from paraffin with 
two changes of xylene and rehydrated in a graded series of ethanol and 
distilled water.
BrdU detection was based on procedures described by Schutte et al. 
(1987a,b). After washing three times for 5 min in PBS the sections were 
pre»treated with pepsin (Boehringer Mannheim, Mannheim, Germany; lot 
no. 108057, 2500 U/mg) in 0.1 N HC1 for 30 min at 3 7 °C, rinsed in PBS 
(three times for 5 min), and then incubated at 37 °C  in 2 N  HC1 to obtain 
single-stranded DNA for the presentation of the antigenic BrdU sites, Sub­
sequently, the pH was neutralized by washing twice in 0.1 M sodium 
tetraborate buffer (Merck), pH  8.5» and three times in PBS. Next, the sec­
tions were incubated overnight at 4°C with the mouse MAb to BrdU 
(1:50,000), rinsed in PBS (three times for 10 min), and incubated with 
peroxidase-conjugated rabbit and-mouse IgG immunoglobulins (Dakopatts; 
1:200) for 1 hr at room temperature (RT). The slides were then washed 
three rimes in PBS and the antibody binding sites visualized by submers­
ing the slides in a peroxidase substrate. Finally the sections were counter­
stained with Mayer's hematoxylin, As a control, the MAb to BrdU was sub­
stituted by a mouse MAb that was not related to BrdU.
To detect NE, E, DBH, and PNMT, indirect immunoenzymatic tech­
niques with peroxidase- and alkaline phosphatase-conjugated immunoglob­
ulins were used. After three 10-min rinses in PBS (pH 7.4), slides were in­
cubated with primary and conjugated antisera, if necessary preceded by 
one of the Unking immunoglobulins, as indicated in Table 1 , The sections 
were rinsed at RT with 0.1 M PBS, pH 7.4, before and after each incubation 
step (three times for 10 min). Next, they were exposed to a peroxidase (1-2 
min) or alkaline phosphatase substrate (10-15 min). After rinsing in run­
ning tapwater (10 min), the peroxidase-stained slides were incubated for 
1 min in a cupric sulfate (CuSO/{) solution (0 .5 % NaCl in 0.5 % CuSO^). 
Sections were counterscained with Mayer’s hematoxylin.
Table 1. Antibodies used for immunoenzymatic detection 
ofNE, E, DBH, and PNMTa____________________________
Primary antibodies 
Goat anri-bovine DBH 1:1600  (Goldstein et al., 1971)
Goat anti-bovine PNMT 1:1600 (Goldstein et al., 1971)
Sheep anti-norepinephrine 1:6400 (Verhofstad et aL, 1983)
Rabbit anti-epinephrine 1:3200 (Verhofstad et al., 1983)
18 hr (overnight), 4°C 
Linking antibodies 
Fluorescein-conjugated rabbit anti-goat immunoglobulins 
(Dakopatts; code F 250, lot 074) 1:50 
Rabbit anti-sheep immunoglobulins (Dakopatts; code Z 181, lot 
111) 1:100 
45 min, room temperature 
Conjugated antibodies 
Peroxidase-conjugated swine anti-rabbit immunoglobulins
(Dakopatts; code P 217, lot 079) 1:40, 45 min,
room temperature 
Alkaline phosphatase-conjugated swine anti-rabbit
immunoglobulins (Dakopatts; code D 306 , lot 1 2 1 ) 1:20,
30 min, room temperature
a For details of the staining protocol for catecholamines and biosynthesizing 
enzymes, see Materials and Methods.
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Simultaneous Staining of NE and E. Sections were incubated with a 
mixture of rabbit antibodies to E and sheep antibodies to  NE, and rinsed 
in PBS. To stain E, sections were incubated with alkaline phosphatase- 
conjugated swine anti*rabbit immunoglobulins, rinsed in PBS, and stained 
with Fast Blue substrate. Next, to stain NE, sections were rinsed in  PBS, 
incubated with 10% normal rabbit serum, and rinsed in PBS. Finally they 
were incubated with alkaline phosphatase- or peroxidase-conjugated rab­
bit anti-sheep immunoglobulins (Dakopatts; code Pl63, lot 039), rinsed 
in PBS, stained with the Fast Red or AEC substrate, respectively, and rinsed 
in running tapwater.
Simultaneous Staining of Catecholamines or Catechol amine- biosyn- 
thesizing Enzymes and BrdU. For simultaneous immunocytochemical de­
tection of BrdU and NE, E, DBH, or PNMT, we considered three possibili­
ties: (a) staining of BrdU followed by staining of the cytoplasmic antigens;
(b) staining of NE, E, DBH, or PNMT followed by detection of BrdU; and
(c) detection of both antigens simultaneously using a mixture of the pri­
mary antibodies.
To determine which of the options was the most appropriate, a series 
of experiments were performed using the methods described above, First, 
by changing the concentration of pepsin in 0.1 N HC1 from 0 (control) 
to 0.2 mg/ml and varying the incubation with 2 N HC1 from 0 (control) 
to 4, 8, 15, 20, and 30 min, the optimal DNA denaturation procedure 
to stain BrdU was determined for different types of tissue. Second, the ef­
fects of these steps on the immunocytochemical staining of NE, Et DBH, 
and PNMT were analyzed. These experiments (see Results) showed that 
only option b, i.e., staining of NE, E, DBH, or PNMT followed by detec­
tion of BrdU, was feasible.
In detail, for the simultaneous detection of BrdU and NE, E, DBH, 
or PNMT in rat adrenal medulla, sections were first incubated with anti­
bodies to NE, E, DBH, or PNMT, followed, in the case o f NE, DBH, and 
PNMT, by one of the linking antibodies mentioned in Table 1. Sections 
were then incubated with alkaline phosphatase-conjugated im m unoglob­
ulins, rinsed in PBS, and stained with an alkaline phosphatase enzyme sub­
strate and rinsed in running tapwater. To detect BrdU, sections were first 
rinsed in PBS and incubated in 0.05 mg/ml pepsin in 0.1 N HCI for 30 
min at 37°C, then incubated in 2 N HCI of 37“C for 18 m in and rinsed 
in 0.1 M sodium tetraborate buffer, pH 8.5, twice for 5 m in. Next, sections 
were rinsed in PBS, incubated with BrdU antibody diluted in 0.15 M PBS 
containing 2% normal rabbit serum, 2% bovine albumin, and 0.1% Tri­
ton X-100 (Sigma), rinsed in PBS again, and incubated with peroxidase- 
conjugated rabbit anti-mouse immunoglobulins. Sections were then stained 
with the DAB substrate, rinsed in running tapwater, incubated in CUSO4 
solution, and rinsed again in running tapwater. If needed, sections were 
counterstained with Mayer’s hematoxylin.
For simultaneous staining of BrdU as well as NE and E (triple labeling), 
sections were first processed according to the simultaneous staining proce­
dure for NE and E, as described above, then rinsed in PBS and processed 
for detection of BrdU incorporation as described above.
Enzyme Substrates. The substrate solution used for staining of the 
peroxidase-labeled immunoglobulins was prepared by dissolving 0.65 % di- 
aminobenzidine tetrahydrochloride (DAB) (Sigma; D 5637) in 0,15 M PBS 
with 6.5% imidazole, to which H 2O2 (0.01%) was added just before use. 
Alternatively, 40 mg 3-ami noethyl-9-carbazole (AEC) (Aldrich Chemie; Brus­
sels, Belgium) was dissolved in 10 ml AW-dimethylformamide and added 
to 190 ml sodium acetate buffer, pH 4.8. Finally, 70 \l[ H 2O 2 was added 
just before use.
For staining of the alkaline phosphatase-labeled immunoglobulins, the 
following solution was prepared; 4 mg naphthol AS-MX phosphate (Sigma; 
N-5000) in 20 ml of 0.2 M Tris with 0.02 mM MgCh, pH  8.5, and 4.8 
mg levamisole (Sigma; lr9756) to block endogenous alkaline phosphatase. 
Just before staining, 20 mg Fast Red TR salt (Sigma; F-1500) was added, 
and subsequently the solution was filtered and applied directly to the tis-
sue sections. A Fast Blue substrate was prepared by dissolving 2 m g naphthol 
AS-TR phosphate (Sigma; N-6125), 6 mg Fast Blue B (Sigma; D-3502) and
1.2 mg levamisole in 5 ml of 0.2 M Tris, 0.02 mM MgCh, pH  8.5,
Stained sections were mounted in Kaiser’s glycerol gelatin (Merck) and 
examined with a Zeiss Axiophot microscope. Black-and-white photomicro­
graphs were made using Agfapan APX 25 professional film  and printed 
on Kodak Polycontrast III RC photopaper. Color prints were taken from 
color slides made using Kodak Ektachrome 64 T film.
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Results
In the peritoneal cavity of the rats, no inflammation or formation 
of adhesions was observed after BrdU administration for 1 or 2 weeks.
BrdU  Detection in Per fusion-fixed Tissue
Sections were carefully screened to determine the precise localiza­
tion and intensity of the staining reactions as well as the degree 
of structural preservation of cells and other tissue components. As 
shown in Table 2, we found that for detection of the incorporated 
BrdU, tissues fixed by perfusion with 4% paraformaldehyde re­
vealed different optimal pepsin pre-treatment and DNA denatu­
ration conditions. The adrenal medulla appeared to be much more 
sensitive to pepsin treatment than kidney and duodenum. At a 
pepsin concentration of 0.05 mg/ml the morphology of the adre­
nal medullary cells was already damaged, whereas in the kidney 
and duodenum cells were not affected at all. Differences also exist 
with regard to DNA denaturation with 2 N  HCI. In  the adrenal 
medulla BrdU staining remained intense only within a small time 
interval, i.e., 15-20 min. In the duodenum and kidney, however, 
2 N  HCI incubation time was less critical.
In all rats treated with BrdU, labeling was found throughout 
the epithelium of the duodenum, indicating that the BrdU treat­
ment of the animals was adequate.
Effect o f  Pepsin and 2 N  HCI on 
Immunocytochemistry o f  the 
Cytoplasmic Antigens
By immunocytochemical staining of NE, E, DBH, and PNMT, NE- 
and E- storing cells could be identified, as indicated in Table 3. 
However, if the immunocytochemical labeling of NE and E, either 
by immunofluorescence or immunoenzymatic staining, was per­
formed after pepsin and HCI pre-treatment in these cells, the nuclei 
instead of the cytoplasm became stained. Pepsin was found to be 
responsible for this phenomenon. At a concentration of 0.2 mg/ml, 
pepsin destroyed the cytoplasm completely, whereas the cell nuclei 
became intensely stained (Figure 2). At lower concentrations of pep­
sin the cytoplasm was less affected but the cell nuclei were also less
Table 2, Optimal pepsin and HCI pre-treatment to stain 
BrdU in cell nuclei o f formaldehyde-fixed iissuesa
Adrenal
medulla Kidney
i
Liver Pancreas Duodenum
Pepsin (m g/m l) 0.02 0.05 0.05 0.1 0.1
2 N  HCI (min) 15 8 30 30 30
a For details of the BrdU staining protocol, see Materials and  Methods.
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Table 3. Staining pattern o f NE- and E-storing cells in adrenal 
medulla o f the rat using immunocy tochemical techniques
Immu no reactivity to
NE E DBH PNMT
NE cells + 4- -  + + -
E cells + + + + + 4- +
a + + , strong reaction; + ,  moderate reaction; -  , no reaction,
h DBH is the biosynthesizing enzyme that converts dopamine into NE and is 
therefore present in both cell types, PNMT is involved in the conversion of NE into 
E and is therefore present only in E cells.
intensely stained. Even with the pepsin concentration needed for 
adequate BrdU staining (0,02 mg/ml for adrenal medullary cells), 
cell nuclei still showed some staining for NE or E.
If the cytoplasmic antigens were first labeled by immunoen­
zymatic staining with DAB, AEC, Fast Red, or Fast Blue, treatment 
with pepsin or 2 N HC1 did not affect or affected only slightly the 
staining properties of the NE and E cells. Only the DAB and AEC 
enzyme products were slightly bleached by 2 N HC1, whereas pep­
sin treatment showed no loss of staining quality.
Double Labeling
The combination of Fast Red alkaline phosphatase staining of the 
cytoplasmic antigens NE, E, DBH, and PNMT, and DAB peroxi­
dase staining of BrdU, gave the best contrast and staining quality, 
Both labeling procedures did not interfere except for the fact that 
the pepsin concentration and the duration of HC1 treatment had 
to be adjusted slightly (see Materials and Methods). BrdU-positive 
cell nuclei could easily be recognized in alkaline phosphatase-labeled 
as well as unlabeled cells.
Figure 1 shows serial sections of a rat adrenal gland after 2 weeks 
of BrdU administration stained for BrdU and NE, E, DBH, or 
PNMT Two types of adrenal medullary cells can be observed, i.e., 
NE-storing cells (only immunoreactive to NE and DBH) and 
E-storing cells (immunoreactive to NE, DBH, E, and PNMT) (see 
Table 3). Cell nuclei with BrdU incorporation are randomly local­
ized throughout the adrenal medulla (Figures la and lb). As shown 
in Figures lc, Id, and If, many E cells have incorporated BrdU and 
a few NE cells possess stained nuclei. In the adrenal medullary cells 
mitotic figures are rarely seen. In one of the double-labeling ex­
periments a cell immunoreactive to E contained a mitotic figure 
stained for BrdU (Figure 3c). In serial sections the cytoplasm of 
this particular cell also stained positive for PNMT and DBH (not 
shown). Mitotic figures in NE-storing cells were not found.
For simultaneous labeling of NE and E, the combination of im- 
munoenzymatic staining using AEC or Fast Red with Fast Blue as 
substrate gave good results. Figure 3a shows an alkaline phospha­
tase double labeling of NE and E in which first E is stained with 
Fast Blue followed by Fast Red staining of NE.
Triple Labeling
By comparing simultaneous immunoenzymatic staining of NE, E, 
and BrdU and single-staining procedures, we found no interfer­
ence between the three different labels. Figure 3b shows a section
of the adrenal medulla of a rat that had received BrdU for 2 weeks, 
stained according to the triple labeling procedure. Separate NE and 
E cells are clearly demonstrated. Some of the E cells had appar­
ently incorporated BrdU.
BrdU Staining Pattern of the Adrenal Medulla
Analysis of the sections stained according to the double- or triple- 
staining procedures described showed that, in addition to the NE- 
and E-storing cells, most of the endothelial cells also had incorpo­
rated BrdU. Ganglion cells were negative.
Discussion
It is now generally accepted that in the adrenal medulla of adult 
rats two different cell types are involved in the biosynthesis of NE 
and E. These cells, the NE- and E-storing cells, can be identified 
by immunocytochemical techniques using antibodies to NE, E, 
DBH, and PNMT. As discussed elsewhere, application of antibod­
ies to NE and E is not limited by the variable degree of crossreac­
tivity encountered with the antisera to the biosynthesizing enzymes 
(Verhofstad et al., 1980,1983,1985,1989; see also Verhofstad, 1993).
Quantitative information on cell proliferation and cell loss is 
needed to understand why organs grow, decline, or stay in a steady- 
state situation. In addition, such information might be helpful to 
understand cell behavior during neoplastic growth and other patho­
logical processes.
Procedures to demonstrate cell proliferation based on the im­
munocytochemical detection of BrdU incorporated into DNA dur­
ing the S-phase of the cell cycle are well established (e,g,, De Brume 
et al.* 1992; Hyatt and Beebe, 1992; Frederiks et al., 1990; De Fa­
zio et al., 1987; Schutte et al., 1987a). These procedures are also 
suitable to study cell proliferation in the rat adrenal medulla (Verhof­
stad, 1993).
To examine separately the proliferation rate of the NE- and 
E-storing cells in the adrenal medulla, we tried to combine the im­
munocytochemical techniques to identify NE- and E-storing cells 
and BrdU incorporation. If applied to two adjacent sections, in most 
cases it was hardly possible to determine the cytoplasmic character­
istics of cells containing BrdU-stained nuclei, Therefore, we decided 
to perform both procedures on the same section. For practical rea­
sons we decided to use paraffin-embedded material only.
For simultaneous staining of BrdU and cytoplasmic markers, 
previous authors have adopted double immunofluorescence (e.g., 
Penit, 1988; Watanabe and Raff, 1988; Houck and Loken, 1985), 
double immunoenzymatic procedures (e.g., Montuenga et al., 1992; 
Soriano and Del Rio, 1991; Harms et al., 1987; Schutte et al., 1987a),
or a combination of immunofluorescence and immunoenzymatic 
staining (Magaud et al., 1989). In studying these options we noted 
that the procedures needed to obtain positive staining of BrdU in 
formaldehyde-fixed tissue reduced the antigenicity of NE, E, DBH, 
and PNMT. In addition, if these procedures were applied to sec­
tions previously stained with an indirect immunofluorescence tech­
nique, loss of fluorescence was observed. Therefore, we decided to 
explore only immunoenzymatic methods in detail.
In combining immunoenzymatic staining of NE, E, DBH, or 
PNMT and BrdU, several problems were encountered. First, be­
cause the immunogens used to raise antibodies to NE and E were
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Figure 1. Rat adrenal gland exposed to BrdU for 2 weeks, fixed by perfusion with 4% paraformaldehyde, and embedded in paraffin. Serial sections (4 |im) stained 
for bromodeoxyuridine and (a) norepinephrine, (b) epinephrine, (e) dopamine p-hydroxylaset or (f) phenylethanolamine-N methyltransferase. c and d are enlarge­
ments of areas indicated by rectangles in a and b, respectively, e and f are areas comparable to c and d. Long arrows (c,d,f) point to nuclei of norepinephrine 
cells (NE) with BrdU incorporation. Short arrow marks nucleus of endothelial cell with BrdU. C, adrenal cortex; E, epinephrine. Bars: a,b = 100 jim; c-f = 30 jim.
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Figure 2. Rat adrenal gland exposed to BrdU for 2 weeks, fixed by perfusion 
with 4% paraformaldehyde, and embedded in paraffin, Section pre-treated with 
0.2 mg/ml pepsin in 0.1 H HCl for 30 min at 37°C. Indirect immunofluorescence 
(FITC) staining with a rabbit antiserum to epinephrine. Note that nuclei Instead 
of the cytoplasm of epinephrine-storing cells are stained. NE, norepinephrine- 
storing cells; C, adrenal cortex. Bar » 30 nm.
synthesized using formaldehyde as a coupling reagent, to identify 
the NE- and E-storing cells tissue fixation with formaldehyde was 
needed (Verhofstad et al., 1980,1983). Previous studies have shown 
that under these conditions DBH and PNMT can be demonstrated 
as well (Verhofstad et al., 1985,1989). To detect BrdU other fixa­
tives are more suitable. However, in sections of formaldehyde-fixed
tissue reliable staining of BrdU can be obtained if the sections are 
pre-treated with pepsin (Schutte et al., 1987b). Second, in previ­
ous studies on the NE- and E-storing cells of the adrenal medulla, 
cryostat sections instead of sections from paraffin-embedded ma­
terial were recommended. However, if formaldehyde fixation is per­
formed by intracardial perfusion, most of the NE and E im- 
munoreactivity is retained in paraffin-embedded tissue (Neelissen 
and Verhofstad, unpublished observation). These experiments also 
indicated that DBH and PNMT immunoreactivity is still present 
in paraffin sections of form aldehyde-feed adrenal glands. As shown 
by Schutte et al. (1987a,b), cryostat as well as paraffin sections can 
be used for immunocytochemical detection of BrdU. Third, the 
proliferation rate of adrenal medullary cells has been shown to be 
rather low. Therefore, to obtain a sufficient number of BrdU-hbeled 
cell nuclei within one section it was necessary to apply BrdU by 
continuous infusion using mini-osmotic pumps implanted into the 
peritoneal cavity. Finally, to give the BrdU antibody access to the 
BrdU incorporated into cell nuclei, DNA must be denatured to 
obtain single-stranded DNA. DNA denaturation procedures re­
ported in the literature are based on the exposure of tissue sections 
to heat, alkaline, or acid (Soriano and Del Rio, 1991; Hayashi et 
al,, 1988; Schutte et aL, 1987 b; Sugihata et aL, 1986; Moran et 
al., 1985). More recently, a procedure using treatment of sections 
with the enzyme nuclease was reported. However, if cross-linking 
fixatives such as formaldehyde arc used, additional deproteinizing 
by pepsin is needed (Dinjens et ah, 1992; Montuenga et al., 1992). 
We have applied DNA denaturation with 2 N HCl because this 
procedure is most effective and because other procedures require 
an even stronger pepsin pre-treatment (Dinjens et al., 1992).
Using pepsin prc-treatment and HCl denaturation in paraffin 
sections from several organs, distinctly BrdU-stained cell nuclei could 
be observed. Our study confirms previous experiments by Dinjens
Figure 3. Rat adrenal glands exposed to BrdU for 2 weeks, fixed by perfusion with 4% paraformaldehyde, and embedded in paraffin, (a) Section stained for norepi­
nephrine (red, Fast Red) and epinephrine (blue, Fast Blue), (b) Section stained for BrdU (brown, DAB), norepinephrine (red, AEC), and epinephrine (blue, Fast 
Blue). Only E cells show nuclei with BrdU incorporation (white arrowheads). In most cases these positive cell nuclei occur in pairs, (c) Section stained for BrdU 
(brown, DAB) and E (red, Fast Red). Mitotic figure In E-immunoreactive cell shows BrdU incorporation. Bar = 20 urn.
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et al. (1992) and Montuenga (1992) indicating that the optimal 
conditions with regard to pepsin and HC1 p re-treatment might differ 
significantly in different tissues.
Based on a series of single experiments we developed a double 
immunoenzymatic staining procedure in which first NE, E, DBH, 
or PNMT is detected by an indirect alkaline phosphatase (AP) reac­
tion with a Fast Red substrate followed by an indirect immunoperox- 
idase reaction developed with DAB to demonstrate BrdU. The 
AP-Fast Red reaction product appeared not to be affected by pep­
sin pre-treatment and HC1 denaturation. Fast Blue or New Fuch- 
sin as a substrate for AP and DAB or aminoethylcarbazoie (AEC) 
as substrates for the peroxidase reaction also appeared to be resis­
tant to pepsin pre-treatment and HC1 denaturation. However, al­
though other combinations are feasible, we prefer the use of Fast 
Red and DAB because of the high contrast of this combination. 
The sensitivity and localization obtained by the double-labeling 
procedure equal that of the single labeling of NE, E, DBH, PNMT, 
and BrdU. In addition, for triple labeling of NE, E, and BrdU and 
double labeling of NE and E, the sensitivity and localization of 
the immunoreactive material were the same as in the single-im- 
munostaining experiments,
Although the present study was not aimed to examine the 
proliferation of the medullary cells in great detail, in the adrenal 
medulla of 9-week»old Wistar rats exposed for 2 weeks to BrdU 
some interesting observations were made. Sections stained accord­
ing to the double- and triple-labeling procedures showed randomly 
distributed BrdU-positive nuclei throughout the medulla in both 
NE- and E-storing cells. Occasionally we identified mitotic figures, 
positively stained for BrdU, in cells that, based on the staining pat­
tern of the cytoplasm, appeared to be fully differentiated, i.e.., 
showed immunoreactivity to E, PNMT, or DBH. We did not find 
mitotic figures in cells stained for NE, most likely because mitotic 
figures are very rare. These findings indicate that in the adrenal 
medulla fully differentiated medullary cells are able to divide. How­
ever, it can not be excluded that part of the BrdU staining is the 
result of BrdU uptake by some kind of progenitor cell. Our obser­
vations confirm previous immunocytochemical studies using simul­
taneous staining of PNMT and BrdU (Tischler et aL, 1989) and 
electron microscopic studies that revealed mitotic figures in cells 
containing both typical NE and E storage granules (Tischler et al., 
1988). However, the advantage of our double- and triple-labeling 
procedures is that we can detect catecholamine-biosynthesizing en­
zymes as well as NE and E in cells that have incorporated BrdU. 
In particular, the applicability of antibodies to NE and E makes 
it possible to study cell proliferation in tissues of species contain­
ing biosynthesizing enzymes that do not crossreact with the cur­
rently available antibodies to DBH or PNMT (Verhofstad et al.,
1980,1983,1985,1989).
In conclusion, we have developed double- and triple-immuno­
enzymatic procedures that enable simultaneous staining of BrdU 
and NE- or E-storing cells. It is probable that the procedures de­
scribed might also be applicable to other tissues containing 
catecholamines or other related monoamines.
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